La pénurie d'Ozempic perdurera jusqu'en 2024, prévient Santé Canada

Diabetes drug Ozempic is shown at a pharmacy in Toronto on Wednesday, April 19, 2023. Health Canada says it is working with manufacturers to make diabetes drugs, including Ozempic, more available during a worldwide shortage fuelled by high demand. THE CANADIAN PRESS/Joe O'Connal

Health Canada says it is working with manufacturers to make diabetes drugs, including Ozempic, more available during a worldwide shortage fuelled by high demand that's expected to last into the new year.

It says Novo Nordisk, which markets Ozempic, is expecting a shortage in Canada of the 0.25 mg, 0.5 mg and 1 mg injection pens until early2024.

The ´ºÉ«Ö±²¥ Press. All rights reserved.

More Health Stories

Sign Up to Newsletters

Get the latest from ´ºÉ«Ö±²¥News in your inbox. Select the emails you're interested in below.